The Motley Fool··James HalleyJ&J Shrugs Off Market Turbulence With Defensive Healthcare Appeal
Johnson & Johnson shares dropped under 2% as S&P 500 fell 7%, backed by $94.2B revenue, 6% growth, and 63 consecutive dividend increases, though talc lawsuits and Medicare price negotiations pose headwinds.
JNJPTGXKVUEpharmaceuticalDividend King